Allstate Corporation’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.71M | Sell |
34,914
-4,577
| -12% | -$1.27M | 0.08% | 145 |
|
|
2026
Q1 | $11.7M | Buy |
39,491
+11,997
| +44% | +$3.56M | 0.12% | 95 |
|
|
2025
Q4 | $7.51M | Buy |
27,494
+14,342
| +109% | +$3.9M | 0.1% | 127 |
|
|
2025
Q3 | $3.55M | Buy |
13,152
+12,314
| +1,469% | +$3.35M | 0.08% | 136 |
|
|
2025
Q2 | $231K | Sell |
838
-11,692
| -93% | -$3.18M | 0.02% | 159 |
|
|
2025
Q1 | $3.32M | Buy |
12,530
+1,844
| +17% | +$455K | 0.1% | 133 |
|
|
2024
Q4 | $2.48M | Buy |
+10,686
| New | +$2.46M | 0.07% | 145 |
|
|
2024
Q2 | – | Sell |
-1,225
| Closed | -$264K | – | 220 |
|
|
2024
Q1 | $264K | Sell |
1,225
-87
| -7% | -$18.3K | 0.02% | 183 |
|
|
2023
Q4 | $276K | Sell |
1,312
-21
| -2% | -$4.48K | 0.02% | 165 |
|
|
2023
Q3 | $267K | Hold |
1,333
| – | – | 0.02% | 169 |
|
|
2023
Q2 | $247K | Sell |
1,333
-8
| -0.6% | -$1.48K | 0.02% | 183 |
|
|
2023
Q1 | $257K | Sell |
1,341
-11,674
| -90% | -$2.11M | 0.02% | 166 |
|
|
2022
Q4 | $2.19M | Buy |
13,015
+4,649
| +56% | +$808K | 0.07% | 185 |
|
|
2022
Q3 | $1.48M | Sell |
8,366
-941
| -10% | -$186K | 0.04% | 242 |
|
|
2022
Q2 | $1.91M | Sell |
9,307
-12,535
| -57% | -$2.66M | 0.06% | 194 |
|
|
2022
Q1 | $5.2M | Sell |
21,842
-7,575
| -26% | -$1.78M | 0.14% | 108 |
|
|
2021
Q4 | $6.72M | Buy |
29,417
+21,227
| +259% | +$4.67M | 0.13% | 121 |
|
|
2021
Q3 | $1.58M | Sell |
8,190
-754
| -8% | -$153K | 0.07% | 174 |
|
|
2021
Q2 | $1.9M | Sell |
8,944
-1,152
| -11% | -$243K | 0.06% | 156 |
|
|
2021
Q1 | $2.06M | Buy |
10,096
+1,723
| +21% | +$339K | 0.06% | 148 |
|
|
2020
Q4 | $1.52M | Sell |
8,373
-619
| -7% | -$105K | 0.05% | 191 |
|
|
2020
Q3 | $1.5M | Sell |
8,992
-2,291
| -20% | -$386K | 0.05% | 156 |
|
|
2020
Q2 | $1.83M | Sell |
11,283
-2,502
| -18% | -$448K | 0.06% | 127 |
|
|
2020
Q1 | $2.38M | Sell |
13,785
-15,232
| -52% | -$3.03M | 0.09% | 88 |
|
|
2019
Q4 | $5.82M | Sell |
29,017
-677
| -2% | -$139K | 0.11% | 115 |
|
|
2019
Q3 | $6.28M | Hold |
29,694
| – | – | 0.11% | 94 |
|
|
2019
Q2 | $5.76M | Buy |
29,694
+2,013
| +7% | +$371K | 0.1% | 105 |
|
|
2019
Q1 | $4.56M | Buy |
27,681
+34
| +0.1% | +$6.01K | 0.12% | 117 |
|
|
2018
Q4 | $5.2M | Buy |
+27,647
| New | +$5.11M | 0.17% | 86 |
|
|
2017
Q3 | – | Sell |
-11,912
| Closed | -$1.49M | – | 74 |
|
|
2017
Q2 | $1.49M | Sell |
11,912
-608
| -5% | -$72.7K | 0.08% | 128 |
|
|
2017
Q1 | $1.49M | Sell |
12,520
-11,594
| -48% | -$1.39M | 0.09% | 144 |
|
|
2016
Q4 | $2.78M | Buy |
+24,114
| New | +$2.68M | 0.17% | 154 |
|
Other funds holding CME
Allstate Corporation's CME Position: Q2 2026 in Review
Allstate Corporation reduced its CME Group (CME) stake by 12% in Q2 2026, selling an estimated $1.27M and leaving 34,914 shares worth $7.71M. The position accounts for 0.08% of the portfolio, ranked #145.
Allstate Corporation first reported a position in CME in Q4 2016 and has held it in 32 quarters since. The position peaked at $11.7M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Allstate Corporation held 34,914 shares of CME Group worth $7.71M as of Q2 2026.
- Allstate Corporation sold 4,577 CME Group shares in Q2 2026, an estimated $1.27M.
- CME Group made up 0.08% of Allstate Corporation's portfolio in Q2 2026, its #145 holding.
- Allstate Corporation first reported a position in CME Group in Q4 2016 and has held it in 32 quarters since.
- Allstate Corporation's CME Group position peaked at $11.7M in Q1 2026.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.